Pippa A. Radcliffe

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

G. Ralph, Pippa A. Radcliffe, Denise M. Day et al. · Nature Medicine · 2005 · 499 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Rnai Protects +8

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

Stéphane Palfi, Jean Marc Gurruchaga, G. Ralph et al. · The Lancet · 2014 · 432 citations

Gene Therapies, Neurodegenerative Diseases, Dose Escalation +11

Localised axial progenitor cell populations in the avian tail bud are not committed to a posterior Hox identity

Michael J. McGrew, Adrian Sherman, Simon Lillico et al. · Development · 2008 · 185 citations · Full text

Cell Specialization, Posterior Hox Identity, Embryology +19

Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector

Bruce Whitelaw, Pippa A. Radcliffe, William A. Ritchie et al. · FEBS Letters · 2004 · 141 citations · Full text

Identification of Novel Temperature-sensitive Lethal Alleles in Essential β-Tubulin and Nonessential α2-Tubulin Genes as Fission Yeast Polarity Mutants

Pippa A. Radcliffe, Dai Hirata, Dylan Z. Childs et al. · Molecular Biology of the Cell · 1998 · 84 citations · Full text